LoginRegister
    Following SC orders, CDSCO asks Pharma manfacturers submit data on 66 fixed-dose combinationsFollowing SC orders, CDSCO asks Pharma manfacturers submit data on 66 fixed-dose combinations
    FDA approves Lundbecks intravenous migraine prevention drug Vyepti, to launch in April 2020FDA approves Lundbeck's intravenous migraine prevention drug Vyepti, to launch in April 2020
    Heron Therapeutics Announces FDA Extension of Review Period for NDA for HTX-011 for Management of Postoperative PainHeron Therapeutics Announces FDA Extension of Review Period for NDA for HTX-011 for Management of...
    Violation of price capping of Coronary stent to attract NPPA action; MinisterViolation of price capping of Coronary stent to attract NPPA action; Minister
    Strides Consumer forays into North India marketStrides Consumer forays into North India market
    With USFDA approval in Hand, Esperion to launch Non-Statin Cholesterol drug NEXLETOL for as low as 10 dollarsWith USFDA approval in Hand, Esperion to launch Non-Statin Cholesterol drug NEXLETOL for as low as...
    Top Cos in pharmaceutical supply chain develop Blockchain system to track prescription drugs, stop counterfeitTop Cos in pharmaceutical supply chain develop Blockchain system to track prescription drugs, stop...
    Eli Lilly Completes Acquisition of DermiraEli Lilly Completes Acquisition of Dermira
    ICRA revises domestic pharma industry outlook to negative due to coronavirus outbreakICRA revises domestic pharma industry outlook to negative due to coronavirus outbreak
    Serum Institute to come up with coronavirus vaccine by 2022Serum Institute to come up with coronavirus vaccine by 2022
    Niti Aayog meets Top pharma execs to find ways to mitigate coronavirus impact; DoP seeks export ban on 12 APIsNiti Aayog meets Top pharma execs to find ways to mitigate coronavirus impact; DoP seeks export ban...
    Anglo-French co Novacyt launches CE-IVD Marked novel coronavirus diagnostics testAnglo-French co Novacyt launches CE-IVD Marked novel coronavirus diagnostics test
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    sidekick